An Update on Usage of High-Risk Donors in Liver Transplantation
Haris Muhammad(Greater Baltimore Medical Center), Ahmet Gürakar(Johns Hopkins University), Duha Zaffar(Johns Hopkins University), Peng–Sheng Ting(Johns Hopkins University), Aniqa Tehreem(Sinai Hospital), Behnam Saberi(Beth Israel Deaconess Medical Center), Saleh A. Alqahtani(Cornell University), Cem Şimşek(University Hospital Centre Zagreb), İlker Turan(Ege University)
Cited by 18
Related Papers
The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data
|BMC Complementary and Alternative Medicine|2019|219
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
|Journal of Oncology|2019|134
A global research priority agenda to advance public health responses to fatty liver disease
|Journal of Hepatology|2023|132
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
|JAMA Network Open|2023|108
Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
|American Journal of Transplantation|2016|105